Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma
- PMID: 23842624
- DOI: 10.1007/s11010-013-1753-0
Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma
Abstract
Increasing evidence suggests that dysregulation of microRNAs is correlated with malignant transformation and tumor development. miR-100, a potential tumor suppressor, is downregulated by many human cancers. However, the expression and functions of miR-100 in hepatocellular carcinoma (HCC) are still unclear. The aim of this study was to detect the expression of miR-100 in HCC tissues and investigate its clinicopathological and prognostic significance. Also, the effects of miR-100 on growth and apoptosis of HCC cells and its potential molecular mechanisms were analyzed. Results showed that the expression level of miR-100 in HCC tissues was significantly lower than that in matched non-cancerous liver tissues. Also, low-miR-100 expression was observed to be significantly correlated with higher tumor grade, higher incidence of lymph node metastasis, advanced TNM stage and higher incidence of tumor recurrence in HCC patients. Multivariate survival analyses suggested that low-miR-100 expression was an independent prognostic factor for HCC patients (HR = 1.66, 95 % CI 1.32-2.82, P = 0.019). In addition, we found that upregulation of miR-100 could inhibit growth and increase apoptosis of HCC cells by downregulating polo-like kinase 1 (plk1). In HCC tissues, miR-100 expression was inversely correlated with the expression of plk1 protein (r = -0.418; P = 0.029). Therefore, downregulation of miR-100 was correlated with progressive pathological feature and poor prognosis in HCC patients, and miR-100 could function as a tumor suppressor by targeting plk1. miR-100 may serve as a prognostic marker and molecular therapeutic target in HCC.
Similar articles
-
miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.Tumour Biol. 2016 Feb;37(2):2497-507. doi: 10.1007/s13277-015-4071-1. Epub 2015 Sep 18. Tumour Biol. 2016. PMID: 26385772
-
MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.BMC Cancer. 2012 Nov 14;12:519. doi: 10.1186/1471-2407-12-519. BMC Cancer. 2012. PMID: 23151088 Free PMC article.
-
MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.J Transl Med. 2013 Aug 22;11:195. doi: 10.1186/1479-5876-11-195. J Transl Med. 2013. PMID: 23967867 Free PMC article.
-
The role of miRNA125b in the progression of hepatocellular carcinoma.Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101712. doi: 10.1016/j.clinre.2021.101712. Epub 2021 Apr 27. Clin Res Hepatol Gastroenterol. 2021. PMID: 33930594 Review.
-
A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma.Can J Gastroenterol Hepatol. 2024 Mar 18;2024:2211179. doi: 10.1155/2024/2211179. eCollection 2024. Can J Gastroenterol Hepatol. 2024. PMID: 38529202 Free PMC article. Review.
Cited by
-
MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer.Int J Colorectal Dis. 2019 Nov;34(11):1871-1877. doi: 10.1007/s00384-019-03401-3. Epub 2019 Oct 9. Int J Colorectal Dis. 2019. PMID: 31598748
-
Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients.J Genet Eng Biotechnol. 2023 Aug 17;21(1):85. doi: 10.1186/s43141-023-00537-2. J Genet Eng Biotechnol. 2023. PMID: 37587273 Free PMC article.
-
A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma.Oncotarget. 2016 Jan 19;7(3):3587-98. doi: 10.18632/oncotarget.6534. Oncotarget. 2016. PMID: 26657296 Free PMC article.
-
MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.Tumour Biol. 2016 Jan;37(1):97-104. doi: 10.1007/s13277-015-4346-6. Epub 2015 Nov 4. Tumour Biol. 2016. PMID: 26537581 Review.
-
Increased hsa-miR-100-5p Expression Improves Hepatocellular Carcinoma Prognosis in the Asian Population with PLK1 Variant rs27770A>G.Cancers (Basel). 2023 Dec 27;16(1):129. doi: 10.3390/cancers16010129. Cancers (Basel). 2023. PMID: 38201556 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous